Loading your page…

Pharmaceutical group

Agepha

11 medicines5 countries

A group of 3 companies with 11 medicines in 5 countries.

Its medicines

Group structure

3 companies in 2 countries

Slovakia2

United States1

Agepha Pharma FzAuthorisation holder · 1 medicine

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

11 medicines

Medicine	Substance	Country	Status	Authorised
Aciclovir Agepha 30 mg/g oogzalfOogzalf	Aciclovir	Netherlands	Authorised	2019
Colchicine AGEPHA Pharma 0,5 mg tablettenTablet	Colchicine	Netherlands	Authorised	2026
LODOCO0.5mg · Tablet	Colchicine	United States	Marketed	2023
Obupro 4 mg/ml oogdruppels, oplossingOogdruppels, oplossing	Oxybuprocaine	Netherlands	Authorised	2023
Ophtesia 4 mg/ml kapi za oko, otopinaKapi za oko, otopina	Oxybuprocaine	Croatia	Not marketed	2023
OXIBUPROCAÍNA HIDROCLORURO AGEPHA 4 MG/ML COLIRIO EN SOLUCIÓN4 mg/ml · Colirio en solución	Oxybuprocaine	Spain	Authorised	2023
Ultracortenol 5 mg/g mast za okoMast za oko	Prednisolone	Croatia	Marketed	2020
Ultracortenol, oogzalf 5 mg/gOogzalf	Prednisolone	Netherlands	Authorised	1989
Xorox 30 mg/g mast za okomast za oko	Aciclovir	Croatia	Marketed	2024
XOROX 30 MG/G POMADA OFTALMICA30 mg · Pomada oftálmica	Aciclovir	Spain	Marketed	2020
Colchicine Agepha Pharma	Colchicine	EU (EMA)	pending

Sources and licences

Country	Medicines	Current	Past	Companies
Netherlands	4	4	0	Companies All medicines
Croatia	3	3	0	Companies All medicines
Spain	2	2	0	Companies All medicines
European Union (EMA)	1	0	1	Companies All medicines
United States	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 12 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR

Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.

Licence: Creative Commons Attribution

Ministerstvo financií Slovenskej republiky / Register účtovných závierok

Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.

Licence: CC0

Report an error or request removalCorrections from the company itself are welcome.

Agepha

Group structure

Slovakia2

United States1

Medicines

Know your medicines, with the sources.

Agepha

Group structure

Slovakia2

United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇸🇰Slovakia2

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Group structure

🇸🇰Slovakia2

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Slovakia2

United States1

Slovakia2

United States1